Zhang, Y., et al. (2016) Calciphylaxis in Peritoneal Dialysis Patients: A Single Center Cohort Study. International Journal of Nephrology and Renovascular Disease, 9, 235-241.
https://doi.org/10.2147/IJNRD.S115701

has been cited by the following article:

• TITLE: A Case Report: Calciphylaxis Presenting as Digital Ischemia in Patient with End Stage Kidney Disease on Peritoneal Dialysis

  AUTHORS: Hatoon Abbas, Manal Alotaibi, Ralph J. Lebron

  KEYWORDS: Calcific Uremic Arteriolopathy, Calciphylaxis, ESKD, PD, HD

  JOURNAL NAME: Open Journal of Nephrology, Vol.9 No.2, May 27, 2019

  ABSTRACT: Calciphylaxis also known as Calcific uremic arteriolopathy (CUA), is a fatal disease with high mortality that mostly affects patients with end stage kidney disease (ESKD) on dialysis. In recent years the incidence of CUA has been increasing among patients on peritoneal dialysis (PD). The exact mechanism and risk factors are not well described.